These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 25597708

  • 1. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
    Yang X, Liu G, Huang Y, Chen S, Du J, Jin H.
    Cardiol Young; 2015 Aug; 25(6):1182-90. PubMed ID: 25597708
    [Abstract] [Full Text] [Related]

  • 2. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
    Chandelia S.
    Cardiol Young; 2015 Aug; 25(6):1228. PubMed ID: 25904322
    [No Abstract] [Full Text] [Related]

  • 3. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 4. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct 17; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of glucocorticoids in addition to intravenous immunoglobulin in the initial treatment of Kawasaki disease: a meta-analysis of randomized trials].
    Hu JW, Zhou ZS, Yang L, Zheng CN, Wang KD.
    Zhonghua Yi Xue Za Zhi; 2011 May 17; 91(18):1259-64. PubMed ID: 21756798
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
    Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
    Cardiol Young; 2015 Oct 17; 25(7):1311-8. PubMed ID: 25544036
    [Abstract] [Full Text] [Related]

  • 7. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Kong WX, Ma FY, Fu SL, Wang W, Xie CH, Zhang YY, Gong FQ.
    World J Pediatr; 2019 Apr 17; 15(2):168-175. PubMed ID: 30809758
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.
    Chen S, Dong Y, Yin Y, Krucoff MW.
    Heart; 2013 Jan 17; 99(2):76-82. PubMed ID: 22869678
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.
    Xu H, Fu S, Wang W, Zhang Q, Hu J, Gao L, Zhu W, Gong F.
    Cardiol Young; 2016 Aug 17; 26(6):1151-7. PubMed ID: 26435202
    [Abstract] [Full Text] [Related]

  • 10. The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
    Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
    J Microbiol Immunol Infect; 2018 Jun 17; 51(3):321-331. PubMed ID: 28927685
    [Abstract] [Full Text] [Related]

  • 11. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H.
    Eur J Pediatr; 2018 Aug 17; 177(8):1279-1292. PubMed ID: 29948255
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ.
    Arch Pediatr Adolesc Med; 2006 Jul 17; 160(7):686-90. PubMed ID: 16818833
    [Abstract] [Full Text] [Related]

  • 13. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 17; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 14. Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease.
    Qiu H, Jia C, Wang Z, He Y, Rong X, Wu R, Chu M, Shi H.
    Balkan Med J; 2020 Oct 23; 37(6):324-329. PubMed ID: 32720495
    [Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease.
    Brogan P, Levin M.
    Evid Based Med; 2013 Dec 23; 18(6):217-8. PubMed ID: 23564929
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
    Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A, RAISE study group investigators.
    Lancet; 2012 Apr 28; 379(9826):1613-20. PubMed ID: 22405251
    [Abstract] [Full Text] [Related]

  • 17. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 28; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 18. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 28; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 19. Kawasaki disease shock syndrome: a severe form of Kawasaki disease.
    İşgüder R, Doksöz Ö, Bağ Ö, Ağın H, Meşe T, Karaarslan ÜU, Devrim İ.
    Turk J Pediatr; 2013 Dec 28; 55(3):319-21. PubMed ID: 24217080
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature.
    Athappan G, Gale S, Ponniah T.
    Cardiovasc J Afr; 2009 Dec 28; 20(4):233-6. PubMed ID: 19701534
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.